Johnson & Johnson recalled another product Wednesday, pulling some vials of its antipsychotic treatment Risperdal Consta after discovering mold during routine quality testing.
Johnson & Johnson recalls vials of antipsychotic treatment
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You